27 related articles for article (PubMed ID: 16621114)
1. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?
Martín-Timón I; Sevillano-Collantes C; Segura-Galindo A; Del Cañizo-Gómez FJ
World J Diabetes; 2014 Aug; 5(4):444-70. PubMed ID: 25126392
[TBL] [Abstract][Full Text] [Related]
2. Brain natriuretic peptide is related to diastolic dysfunction whereas urinary albumin excretion rate is related to left ventricular mass in asymptomatic type 2 diabetes patients.
Magnusson M; Jovinge S; Shahgaldi K; Israelsson B; Groop L; Melander O
Cardiovasc Diabetol; 2010 Jan; 9():2. PubMed ID: 20078898
[TBL] [Abstract][Full Text] [Related]
3. The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study.
Soedamah-Muthu SS; Visseren FL; Algra A; van der Graaf Y;
Diabet Med; 2008 Jan; 25(1):51-7. PubMed ID: 18199132
[TBL] [Abstract][Full Text] [Related]
4. Mild renal insufficiency as a cardiovascular risk factor in non-proteinuric type II diabetes.
Gimeno-Orna JA; Lou-Arnal LM; Boned-Juliani B; Molinero-Herguedas E
Diabetes Res Clin Pract; 2004 Jun; 64(3):191-9. PubMed ID: 15126007
[TBL] [Abstract][Full Text] [Related]
5. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study.
Arnlöv J; Evans JC; Meigs JB; Wang TJ; Fox CS; Levy D; Benjamin EJ; D'Agostino RB; Vasan RS
Circulation; 2005 Aug; 112(7):969-75. PubMed ID: 16087792
[TBL] [Abstract][Full Text] [Related]
6. Triglyceride, albuminuria and blood pressure are the major associations of non-fatal cardiovascular disease in Chinese type 2 diabetes.
Ko GT; Chan JC; Chow CC; Yeung VT; Chan WB; So WY; Ma RC; Ozaki R; Cockram CS
Acta Diabetol; 2003 Jun; 40(2):80-4. PubMed ID: 12861405
[TBL] [Abstract][Full Text] [Related]
7. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients.
Targher G; Bertolini L; Zenari L; Lippi G; Pichiri I; Zoppini G; Muggeo M; Arcaro G
Diabet Med; 2008 Jan; 25(1):45-50. PubMed ID: 18199131
[TBL] [Abstract][Full Text] [Related]
8. Microalbuminuria presents the same vascular risk as overt CVD in type 2 diabetes.
Gimeno-Orna JA; Molinero-Herguedas E; Sánchez-Vaño R; Lou-Arnal LM; Boned-Juliani B; Castro-Alonso FJ
Diabetes Res Clin Pract; 2006 Oct; 74(1):103-9. PubMed ID: 16621114
[TBL] [Abstract][Full Text] [Related]
9. Microalbuminuria, endothelial dysfunction and cardiovascular risk.
Feldt-Rasmussen B
Diabetes Metab; 2000 Jul; 26 Suppl 4():64-6. PubMed ID: 10922975
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of cardiovascular complications in type 2 diabetes mellitus.
Meigs JB
Acta Diabetol; 2003 Dec; 40 Suppl 2():S358-61. PubMed ID: 14704869
[TBL] [Abstract][Full Text] [Related]
11. [Microalbuminuria and non-insulin-dependent diabetes: practical interpretation and therapeutic consequences].
Bouhanick B; Berrut G; Fressinaud P; Marre M
Diabete Metab; 1995 Oct; 21(4):295-8. PubMed ID: 8529767
[No Abstract] [Full Text] [Related]
12. Considerations for treating dyslipidemia in special diabetic populations.
Harmel AP
Diabetes Metab Res Rev; 2002; 18(2):88-95. PubMed ID: 11994899
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
